To prep 2302 for our exploration of the executive branch next week, a radio story about the Food and Drug Administration's ability - given resources allocated to it - to
regulate the sale of drugs, including the ability to detect a remove from the market - counterfeit drug. I'm not absolutely certain, but FDA funding is likely discretionary, so it can be cut at any time. The question is whether doing so is beneficial.